ORLANDO, FL, USA (UroToday.com) - The object of this study was to identify genetic markers in the pharmacokinetic and pharmacodynamic pathway of sunitinib that predispose patients to the development of toxicities.
Your session will expire in 8 hours requiring you to log in each day to view content.